Raptiva

DRUG6 trials

Sponsors

Oregon Health and Science University, Merck KGaA, Darmstadt, Germany, The Cleveland Clinic, National Institute of Dental and Craniofacial Research (NIDCR), University of California, Davis

Conditions

Dermatitis, AtopicDiscoid Lupus Erthematosus of the ScalpHypoglycemiaModerate to Severe PsoriasisPsoriasisSjogren's SyndromeType 1 Diabetes Mellitus

Phase 1

Efalizumab for Moderate to Severe Atopic Dermatitis

CompletedNCT00226057

Oregon Health and Science UniversityDermatitis, Atopic

Start: 2005-06-30End: 2006-05-31Updated: 2020-01-03

Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy

CompletedNCT00368654

University of California, DavisPsoriasis

Start: 2007-01-31End: 2008-05-31Updated: 2018-06-14

Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes

TerminatedNCT00672204

University of MinnesotaHypoglycemia, Type 1 Diabetes Mellitus

Start: 2007-11-30End: 2012-08-31Updated: 2017-10-25

Phase 2

Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva

WithdrawnNCT00308204

The Cleveland ClinicDiscoid Lupus Erthematosus of the Scalp

Start: 2006-03-31End: 2007-08-31Updated: 2020-02-19

Pilot Study of Raptiva to Treat Sjogren's Syndrome

TerminatedNCT00344448

National Institute of Dental and Craniofacial Research (NIDCR)Sjogren's Syndrome

Start: 2006-06-30End: 2009-01-31Updated: 2015-12-21

Phase 3

CLEAR Study: Clinical Experience Acquired With Raptiva Study

CompletedNCT00256139

Merck KGaA, Darmstadt, GermanyModerate to Severe Psoriasis

Start: 2003-03-31End: 2004-10-31Updated: 2017-01-16